Phaos Technology (Cayman) (POAS) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trinity Biotech is the larger company by market cap ($5.6 million vs $4.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | POAS | TRIB |
|---|---|---|
| Share price | $0.138 | $6.86 |
| Market cap | $4.36M | $5.57M |
| 1-day change | -2.82% | +13.49% |
| EPS (TTM) | $-0.38 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.40 | $52.50 |
| 52-week low | $0.132 | $5.01 |
| Distance from 52-week high | -98.13% | -86.94% |
| Average volume | 239.81K | 21.66K |
| Shares outstanding | 16.45M | 813.13K |
| Employees | 10 | 287 |
| Sector | Industrials | Health Care |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Phaos Technology (Cayman) in Industrials and Trinity Biotech in Health Care.
About Phaos Technology (Cayman)
POAS stock →Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore.
Industrials · Industrial Machinery/Components · 10 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
POAS vs TRIB FAQ
Which is bigger, Phaos Technology (Cayman) or Trinity Biotech?
Trinity Biotech (TRIB) is larger, with a market capitalization of $5.57M compared with $4.36M for Phaos Technology (Cayman) (POAS).
Are Phaos Technology (Cayman) and Trinity Biotech in the same industry?
No. Phaos Technology (Cayman) is in the Industrials sector, while Trinity Biotech is in Health Care.